Andecaliximab
1-bromo-2-fluoro-4-methoxy-3-nitrobenzene
Molecular Identity
Andecaliximab
1-bromo-2-fluoro-4-methoxy-3-nitrobenzene
PubChem CID: 56776542
2D Structure
Properties
C7H5BrFNO3
Molecular Formula
250.02
Molecular Weight
g/mol
248.9437
Exact Mass
Da
2.5
XLogP
Drug-like (Lipinski: < 5)
55.1
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
4
H-Bond Acceptors
199
Complexity
SMILES
Canonical SMILES
SMILES: COC1=C(C(=C(C=C1)Br)F)[N+](=O)[O-]Isomeric SMILES
SMILES: COC1=C(C(=C(C=C1)Br)F)[N+](=O)[O-]Synonyms(20)
GS-57451518996-49-0andecaliximabumRefChem:75071GS5745571045EIM4IMMUNOGLOBULIN G4, ANTI-(HUMAN GELATINASE B) (HUMAN-MUS MUSCULUS MONOCLONAL GS-5745 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GS-5745 LIGHT CHAIN, DIMER1-bromo-2-fluoro-4-methoxy-3-nitrobenzene1352317-80-64-Bromo-3-fluoro-2-nitroanisoleMFCD204914211-bromo-2-fluoro-4-methoxy-3-nitro-benzeneSCHEMBL16738853SCHEMBL30673293DTXSID90718324
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Andecaliximab
Loading drug network...